SPP1 and hepatocellular carcinoma: Recent research found that HCC patients who do not respond to anti-PD-1 treatment exhibit an immune barrier near the tumor boundary, composed of CAFs and SPP1+ macrophages, which blocks the infiltration of cytotoxic T cells into the tumor[23].